Naloxone and naltrexone in mental illness and tardive dyskinesia.
D000818:Animals; D002986:Clinical Trials as Topic; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000503:physiopathology; D004723:Endorphins / Q000502:physiology; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy*; D009270:Naloxone / Q000627:therapeutic use*; D009271:Naltrexone / Q000627:therapeutic use; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology
D004723:Endorphins; D009270:Naloxone; D009271:Naltrexone